BRIACELL THERAP Operating Cash Flow Growth

Operating Cash Flow Growth of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Cash Flow Growth for the quarter ending October 31, 2022 was -0.99 (a 39.85% increase compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow Growth decreased by -93.46%
  • Annual Operating Cash Flow Growth for 2022 was -0.61 (a -88.08% decrease from previous year)
  • Annual Operating Cash Flow Growth for 2021 was -5.12 (a -863.27% decrease from previous year)
  • Annual Operating Cash Flow Growth for 2020 was 0.67 (a 5587.29% increase from previous year)
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow Growth of BRIACELL THERAP

Most recent Operating Cash Flow Growthof BCTX including historical data for past 10 years.

Interactive Chart of Operating Cash Flow Growth of BRIACELL THERAP

BRIACELL THERAP Operating Cash Flow Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.99 -0.71 0.14 -15.16 -0.61
2021 -29.61 -3.98 -99.73 -0.18 -5.12
2020 0.93 0.09 1.03 0.75 0.67
2019 0.28 0.58 -0.69 0.29 0.01
2018 -0.04 -15.71 -0.4 -1.57 -1.7
2017 -2.23 0.81 -1.47 -0.08 -0.22
2016 -0.1 -0.16 -0.23 0.39 -0.17
2015 -52.55 -1.2 -1.61 -5.9 -1.74
2014 0.92 0.3 -0.04 -1.07 0.02
2013 -0.06 -0.67 0.3 0.79 0.01
2012 -0.33 0.39 0.48 0.43

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology